Cyclophosphamide for Injection, USP, 1g/vial, Lyophilized, Single Dose Vial, Discard unused solut...

FDA Recall #D-0434-2024 — Class III — April 2, 2024

Recall #D-0434-2024 Date: April 2, 2024 Classification: Class III Status: Terminated

Product Description

Cyclophosphamide for Injection, USP, 1g/vial, Lyophilized, Single Dose Vial, Discard unused solution, Cytotoxic Agent, After Reconstitution: For direct intravenous injection or must be further diluted before intravenous infusion, Rx Only, Manufactured for: XGen Pharmaceuticals DJB, Inc., Big Flats, NY 14814, NDC # 39822-0255-01.

Reason for Recall

Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

Recalling Firm

X-Gen Pharmaceuticals Inc. — Horseheads, NY

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

1332 vials

Distribution

Nationwide in the US

Code Information

Lot #: CIC2-23001 A, Exp. 11/30/2026

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated